ARTICLE | Company News
Norak, Q3DM, AstraZeneca deal
July 1, 2002 7:00 AM UTC
Norak and Q3DM will combine their screening technologies to study GPCRs. Norak will contribute its Transfluor fluorescence-based GPCR technology for use on Q3DM's EIDAQ 100 High Throughput Microscopy (HTM) platform. The companies plan to offer the combined technology to pharmaceutical and biotech companies. ...